Who
The study involved patients with pulmonary tuberculosis receiving treatment at Puskesmas Nibung. The population consisted of 97 patients treated in 2023. The study sample included 35 pulmonary tuberculosis patients in 2024 who had been diagnosed with tuberculosis and had undergone treatment for at least two months.
What
The study examined medication adherence to anti-tuberculosis treatment and identified factors associated with adherence. The results showed that 57.1% of respondents were adherent to their medication. Multivariate analysis revealed that gender was the most dominant factor associated with medication adherence. Statistically significant relationships were found between medication adherence and gender, education level, knowledge, employment status, family support, and attitude.
When
Data collection was conducted from March 3 to May 12, 2024.
Where
The study was conducted at the Nibung Community Health Center (UPTD Puskesmas Nibung), North Musi Rawas Regency, Indonesia.
Why
The study was conducted to address the need for understanding medication adherence among pulmonary tuberculosis patients and to identify key factors influencing adherence to anti-tuberculosis treatment.
How
A quantitative analytic survey with a cross-sectional design was used. Total sampling based on inclusion criteria was applied. Data were analyzed using univariate and multivariate analyses to determine factors associated with medication adherence.
Source: Fitri, V.K., Zaman, C., Priyanto, A.D. and Ekawati, D., 2025. Analysis Factor of Compliance With Taking Anti-Pulmonary Tuberculosis Drugs in Patients With Pulmonary Tuberculosis. Lentera Perawat, 6(1), pp.59-68.
